SE503233C2 - Sukralfat beredning och förfarande för framställning av densamma - Google Patents
Sukralfat beredning och förfarande för framställning av densammaInfo
- Publication number
- SE503233C2 SE503233C2 SE8701787A SE8701787A SE503233C2 SE 503233 C2 SE503233 C2 SE 503233C2 SE 8701787 A SE8701787 A SE 8701787A SE 8701787 A SE8701787 A SE 8701787A SE 503233 C2 SE503233 C2 SE 503233C2
- Authority
- SE
- Sweden
- Prior art keywords
- polyethylene glycol
- sucralfate
- turbidity
- acceleration
- preparing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Photoreceptors In Electrophotography (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9990186 | 1986-04-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8701787D0 SE8701787D0 (sv) | 1987-04-29 |
SE8701787L SE8701787L (sv) | 1987-10-31 |
SE503233C2 true SE503233C2 (sv) | 1996-04-22 |
Family
ID=14259677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8701787A SE503233C2 (sv) | 1986-04-30 | 1987-04-29 | Sukralfat beredning och förfarande för framställning av densamma |
Country Status (9)
Country | Link |
---|---|
JP (1) | JP2542210B2 (it) |
DE (1) | DE3714159C2 (it) |
DK (1) | DK167735B1 (it) |
ES (1) | ES2017805A6 (it) |
FI (1) | FI89457C (it) |
FR (1) | FR2598084B1 (it) |
IT (1) | IT1208416B (it) |
NO (1) | NO174085C (it) |
SE (1) | SE503233C2 (it) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2735559B2 (ja) * | 1988-03-02 | 1998-04-02 | 中外製薬株式会社 | 懸濁液 |
ES2173183T3 (es) * | 1994-04-26 | 2002-10-16 | Chugai Pharmaceutical Co Ltd | Procedimiento de preparacion de sucralfato granulado y fundido. |
WO1996023507A1 (fr) * | 1995-02-02 | 1996-08-08 | Chugai Seiyaku Kabushiki Kaisha | Preparation de sucralfate |
ES2112765B1 (es) * | 1995-08-02 | 1999-03-01 | Cantabria Ind Farmaceutica Sa | Procedimiento para la obtencion de formulaciones de constraste radiologico, para exploraciones gastrointestinales de uso extemporaneo y directo. |
WO2011102505A1 (ja) * | 2010-02-22 | 2011-08-25 | 第一三共株式会社 | 経口用徐放性固形製剤 |
WO2011102504A1 (ja) | 2010-02-22 | 2011-08-25 | 第一三共株式会社 | 経口用徐放性固形製剤 |
CN104768552A (zh) | 2012-09-03 | 2015-07-08 | 第一三共株式会社 | 含有盐酸氢吗啡酮的口服持续释放药物组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3430809A1 (de) * | 1984-08-22 | 1986-03-06 | Merck Patent Gmbh, 6100 Darmstadt | Sucralfat-suspension |
-
1987
- 1987-04-28 NO NO871759A patent/NO174085C/no unknown
- 1987-04-28 FI FI871852A patent/FI89457C/fi not_active IP Right Cessation
- 1987-04-28 DE DE3714159A patent/DE3714159C2/de not_active Expired - Lifetime
- 1987-04-29 SE SE8701787A patent/SE503233C2/sv not_active IP Right Cessation
- 1987-04-29 ES ES8701280A patent/ES2017805A6/es not_active Expired - Lifetime
- 1987-04-29 DK DK218587A patent/DK167735B1/da not_active IP Right Cessation
- 1987-04-29 IT IT8767365A patent/IT1208416B/it active
- 1987-04-30 FR FR878706196A patent/FR2598084B1/fr not_active Expired - Lifetime
- 1987-04-30 JP JP62104612A patent/JP2542210B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE3714159A1 (de) | 1987-11-05 |
FR2598084B1 (fr) | 1991-04-26 |
FI89457C (fi) | 1993-10-11 |
ES2017805A6 (es) | 1991-03-01 |
FR2598084A1 (fr) | 1987-11-06 |
SE8701787D0 (sv) | 1987-04-29 |
DK167735B1 (da) | 1993-12-13 |
IT8767365A0 (it) | 1987-04-29 |
DE3714159C2 (de) | 1996-09-19 |
NO871759D0 (no) | 1987-04-28 |
IT1208416B (it) | 1989-06-12 |
NO174085C (no) | 1994-03-16 |
DK218587A (da) | 1987-10-31 |
JPS63107933A (ja) | 1988-05-12 |
FI871852A0 (fi) | 1987-04-28 |
NO871759L (no) | 1987-11-02 |
DK218587D0 (da) | 1987-04-29 |
FI871852A (fi) | 1987-10-31 |
JP2542210B2 (ja) | 1996-10-09 |
SE8701787L (sv) | 1987-10-31 |
NO174085B (no) | 1993-12-06 |
FI89457B (fi) | 1993-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4261970A (en) | Theophylline sustained release granule | |
Millili et al. | The strength of microcrystalline cellulose pellets: the effect of granulating with water/ethanol mixtures | |
EP0124027B1 (en) | Rapid dissolving, uniform drug compositions and their preparation | |
IE880584L (en) | Pharmaceutical tablet, pharmaceutical granulate and process¹for their preparation | |
WO1991018590A1 (en) | Process for the manufacture of porous cellulose matrices | |
GB2249957A (en) | Controlled release composition | |
SE503233C2 (sv) | Sukralfat beredning och förfarande för framställning av densamma | |
CN109248155A (zh) | 一种罗红霉素胶囊及其制备工艺 | |
EP1256338A2 (en) | A process for the preparation of direct tabletting formulations and aids | |
Dabagh et al. | Investigation of solid dispersion technique in improvement of physicochemical characteristics of ibuprofen powder | |
US5514383A (en) | Process for the preparation of tablets of derivatives of cephalosporanic acid by direct compression | |
Ghosh et al. | Effect of particle size on dissolution profile of ciprofloxacin hydrochloride from floating matrix tablet | |
US4012498A (en) | Sustained release tablet formulations | |
US5547943A (en) | Sucralfate preparation | |
CN106265557A (zh) | 含有替格瑞洛的药物组合物 | |
Sahu et al. | Formulation and evaluation of effervescent floating tablet of levofloxacin | |
CN109288810B (zh) | 一种头孢地尼胶囊及其制备方法 | |
CA2024863C (en) | The manufacture of pellets of xanthine derivatives | |
SU1478993A3 (ru) | Способ получени микрогранул | |
CN112023056A (zh) | 一种氟康唑药物组合物及其制备方法 | |
IE42952L (en) | Tablet formulation | |
CN115531330B (zh) | 一种孟鲁司特钠咀嚼片的制备方法 | |
Okolo et al. | Novel applications of locally sourced montmorillonite (MMT) clay as a disintegrant in the formulation of pharmaceutical product | |
RU2816913C2 (ru) | Твердая дисперсия и способ ее получения | |
CN111407737B (zh) | 一种具有高溶出度的氢溴酸高乌甲素片及制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |